MedRhythms Announces Addition of Global Brain Corporation and Bose Ventures to Series B Round

PORTLAND, Maine–(BUSINESS WIRE)–MedRhythms, a leader in developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, today announced the closing of a Series B extension round, with investment from one of Japan’s largest venture capital companies Global Brain with its CVC JGC MIRAI Innovation Fund, and Bose Ventures. The follow-on investment brings the Company’s total Series B financing to $27 million, an increase from their announcement in July. Read more

Related Posts

Maine’s first mobile biolab starts tour of rural schools in Fort Kent

FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...

12 March 2024

UMaine Augusta’s $1.75M medical lab training facility doubles student capacity

Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...

21 February 2024

UNE receives grant to research state-threatened animal

The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...

12 February 2024